Insight Molecular Diagnostics (IMDX) EBIT Margin Growth (1y) (2021 - 2026)
Insight Molecular Diagnostics (IMDX) EBIT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 50.00 |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 519.00 |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 136.00 |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 376.00 |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | -101.00 |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 235.00 |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 93.00 |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 352.00 |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | -78.00 |
| 10 | Insight Molecular Diagnostics | 172.42 Mn | 143.49 Mn | 15,000.00 | -2.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.81 Mn |
| Dec 31, 2025 | 20,541.00 |
| Sep 30, 2025 | 233,152.00 |
| Jun 30, 2025 | 330,037.00 |
| Mar 31, 2025 | 254,165.00 |
| Dec 31, 2024 | 75,587.00 |
| Sep 30, 2024 | -333,834.00 |
| Jun 30, 2024 | -266,249.00 |
| Mar 31, 2024 | -482,936.00 |
| Dec 31, 2023 | -272,679.00 |
| Sep 30, 2023 | 102,809.00 |
| Jun 30, 2023 | -110,528.00 |
| Mar 31, 2023 | 225,868.00 |
| Dec 31, 2022 | 70,215.00 |
| Sep 30, 2022 | -116,375.00 |
| Jun 30, 2022 | -1,770.00 |
| Mar 31, 2022 | 72,169.00 |
| Dec 31, 2021 | 25,178.00 |
| Sep 30, 2021 | -25,748.00 |
| Jun 30, 2021 | 546,309.00 |